Central Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,023
| Closed | -$279K | – | 245 |
|
|
2024
Q2 | $279K | Hold |
3,023
| – | – | 0.04% | 159 |
|
|
2024
Q1 | $289K | Hold |
3,023
| – | – | 0.04% | 162 |
|
|
2023
Q4 | $231K | Buy |
+3,023
| New | +$231K | 0.04% | 169 |
|
|
2023
Q2 | – | Sell |
-33
| Closed | -$2.73K | – | 362 |
|
|
2023
Q1 | $2.73K | Buy |
+33
| New | +$2.73K | ﹤0.01% | 335 |
|
|
2022
Q3 | – | Sell |
-39
| Closed | -$4K | – | 319 |
|
|
2022
Q2 | $4K | Buy |
+39
| New | +$4K | ﹤0.01% | 300 |
|
|
2022
Q1 | – | Sell |
-392
| Closed | -$51K | – | 319 |
|
|
2021
Q4 | $51K | Hold |
392
| – | – | 0.01% | 228 |
|
|
2021
Q3 | $44K | Hold |
392
| – | – | 0.01% | 228 |
|
|
2021
Q2 | $41K | Hold |
392
| – | – | 0.01% | 228 |
|
|
2021
Q1 | $33K | Buy |
+392
| New | +$33K | 0.01% | 228 |
|
|
2019
Q2 | – | Sell |
-186
| Closed | -$12K | – | 266 |
|
|
2019
Q1 | $12K | Hold |
186
| – | – | ﹤0.01% | 221 |
|
|
2018
Q4 | $9K | Sell |
186
-99
| -35% | -$4.79K | ﹤0.01% | 221 |
|
|
2018
Q3 | $17K | Buy |
+285
| New | +$17K | ﹤0.01% | 209 |
|
|
2017
Q2 | – | Sell |
-42
| Closed | -$1K | – | 288 |
|
|
2017
Q1 | $1K | Hold |
42
| – | – | ﹤0.01% | 321 |
|
|
2016
Q4 | $1K | Sell |
42
-222
| -84% | -$5.29K | ﹤0.01% | 315 |
|
|
2016
Q3 | $11K | Buy |
+264
| New | +$11K | ﹤0.01% | 251 |
|